AME · 10-Q · 2026Q3 · Full report

Operating Expense Trends

AMETEK INC/ · 2026-11-03 · Importance 35 · Surprise 22 · No source text

Third-quarter SG&A increased 14.0% to $225.5 million, but declined to 10.2% of sales from 10.4%; selling expense growth primarily reflected higher sales. Nine-month SG&A rose 17.1% to $635.0 million and increased to 10.3% of sales from 10.0%, with higher selling expense attributable to sales growth and recent acquisitions. Research, development and engineering costs increased 15.6% to $327.9 million for the first nine months, including $260.3 million in EIG and $67.6 million in EMG. Nine-month G&A rose to $92.4 million from $82.6 million.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
operating_incomenegativerealized-4.2%AMETEK first-nine-months 2026 selling, general and administrative expenses were $635.0 million, or 10.3% of sales, up $92.8 million or…
operating_incomenegativerealized-1.3%AMETEK third-quarter 2026 selling, general and administrative expenses were $225.5 million, or 10.2% of sales, up $27.7 million or 14.0%…
marginnegativerealized-0.3%AMETEK first-nine-months 2026 selling, general and administrative expenses were $635.0 million, or 10.3% of sales, up $92.8 million or…
marginpositiverealized+0.2%AMETEK third-quarter 2026 selling, general and administrative expenses were $225.5 million, or 10.2% of sales, up $27.7 million or 14.0%…